Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Yulong Eco-Materials Limited - Ordinary Shares (OP:YECO)

0.0885 +0.0063 (+7.66%)
Streaming Delayed Price Updated: 3:42 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Yulong Eco-Materials Limited - Ordinary Shares

News headline image
EV Biologics Updates on Funding and Sales
Via ACCESSWIRE
News headline image
EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic
Via ACCESSWIRE
News headline image
EV Biologics Appoints Senior Investment Banker as Corporate Finance Director
Via ACCESSWIRE
News headline image
EV Biologics Hires Senior Chief Financial Officer
Via ACCESSWIRE
News headline image
EV Biologics Signs Exclusive Distribution Agreement for South America
Via ACCESSWIRE
News headline image
EV Biologics Generates Mesenchymal Stem Cell Lines
Via ACCESSWIRE
News headline image
EV Biologics Updates on Excyte Subsidiary Funding
Via ACCESSWIRE
News headline image
EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX
Via ACCESSWIRE
News headline image
EV Biologics Launches Excyte with $100 million Valuation
Via ACCESSWIRE
News headline image
EV Biologics Signs MSA with LONZA Cell & Gene Therapy
HOUSTON, TX / ACCESSWIRE / May 17, 2022 / EV Biologics Corp, OTC PINK:YECO, today announced that it has signed a Manufacturing Services Agreement (MSA) with Lonza for development of stem/progenitor... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Isolates Primary Cells for Nanoparticle Production & Accelerated Cell Line Development
TAMPA, FL / ACCESSWIRE / April 12, 2022 / EV Biologics Corp, OTC PINK:YECO, today announced that it has succeeded in isolating primary progenitor cells from tissue using a xeno-free process. The... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Updates on FINRA Filings
NASHVILLE, TN / ACCESSWIRE / March 9, 2022 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with the latest information about its submitted FINRA applications for name change and NFT... 
From EV Biologics Corporation
Via AccessWire
Topics Regulatory Compliance
News headline image
EV Biologics Updates on FINRA
NASHVILLE, TN / ACCESSWIRE / January 18, 2022 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its submitted FINRA applications for name change and NFT dividend... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Updates on NFT Dividend
NASHVILLE, TN / ACCESSWIRE / November 12, 2021 / EV Biologics Corp, (OTC PINK:YECO), today updated shareholders with further details about its NFT dividend. The Company is still awaiting approval from... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Signs Listing Agreement With INX
NASHVILLE, TN / ACCESSWIRE / November 11, 2021 / EV Biologics Corp, ("the Company"), OTC PINK:YECO, today confirmed that it has signed an agreement to list its common stock on the INX Securities ATS, a... 
From EV Biologics Corporation
Via AccessWire
Topics Bonds Law Enforcement Regulatory Compliance
News headline image
EV Biologics Chief Medical Officer Publication on COVID-19 & Exosomes
NASHVILLE, TN / ACCESSWIRE / October 28, 2021 / EV Biologics Corp, OTC Pink:YECO, today updated shareholders about a recent publication authored by its Chief Medical Officer, Dr. Jason Sanders. This... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Updates on NFT Minting
NASHVILLE, TN / ACCESSWIRE / September 28, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT and minting progress. Our NFT team has been minting the... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Updates on NFT Warrant Dividend Distribution
NASHVILLE, TN / ACCESSWIRE / August 30, 2021 / EV Biologics Corp, (OTC Pink:YECO), today updated shareholders with further details about its NFT Warrant Dividend distribution. The Company is currently... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Briefs Shareholders on Market Cap Peer Comparison
NASHVILLE, TN / ACCESSWIRE / August 12, 2021 / EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group.... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics NFT Dividend Information
NASHVILLE, TN / ACCESSWIRE / August 9, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT Warrant Dividend. Attached is a preliminary image from the... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics NFT Dividend Warrant Date
NASHVILLE, TN / ACCESSWIRE / July 30, 2021 / EV Biologics Corp., OTC PINK:YECO, today confirmed for share holders its NFT Warrant Dividend shareholders-of-record date. YECO's shareholders-of-record on... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio Services
NASHVILLE, TN / ACCESSWIRE / July 28, 2021 / EV Biologics Corp, OTC PINK:YECO today announced that it has signed an agreement with Lonza Cell Bio Services to implement a custom cell isolation in... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Unveils NFT Dividend Warrant
NASHVILLE, TN / ACCESSWIRE / July 26, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend Warrant. The Company will distribute one (1) Warrant for every 100... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Signs LOI with Lonza Cell & Gene Therapy
NASHVILLE, TN / ACCESSWIRE / July 22, 2021 / EV Biologics Corp., (OTC PINK:YECO) today announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development and... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics NFT Dividend Update
NASHVILLE, TN / ACCESSWIRE / July 19, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend. On July 14, 2021 the Company announced a dividend of 1 NFT for every... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Announces NFT Dividend
CHEYENNE, WY / ACCESSWIRE / July 14, 2021 / EV Biologics Corp, OTC PINK:YECO, today announced that it will distribute a dividend of one (1) Non-Fungible Token (NFT) for every 100 shares of YECO common... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics is now Pink Current
CHEYENNE, WY / ACCESSWIRE / June 14, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now Pink Current. Being current and Penny Stock... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Updates Shareholders on Name and Symbol Change
CHEYENNE, WY / ACCESSWIRE / May 19, 2021 / EV Biologics Corp., OTC PINK:YECO, is taking this opportunity to update our shareholders and other investors concerning the status of our name change... 
From EV Biologics Corporation
Via AccessWire
News headline image
EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome Research
NASHVILLE, TN / ACCESSWIRE / April 8, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a director's loan agreement to secure funding of up to $5 million to start generation... 
From EV Biologics Corporation
Via AccessWire
Topics Derivatives
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.